CHLOROPTIC S.O.P Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chloroptic S.o.p, and when can generic versions of Chloroptic S.o.p launch?
Chloroptic S.o.p is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in CHLOROPTIC S.O.P is chloramphenicol. There are fourteen drug master file entries for this compound. Additional details are available on the chloramphenicol profile page.
Summary for CHLOROPTIC S.O.P
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CHLOROPTIC S.O.P at DailyMed |
US Patents and Regulatory Information for CHLOROPTIC S.O.P
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | CHLOROPTIC S.O.P. | chloramphenicol | OINTMENT;OPHTHALMIC | 061187-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |